A cohort of 469 hospital-referred patients with transient ischaemic attacks (TIA) of the brain (66%) or eye (34%) due to presumed atheromatous thromboembolism, lipohyalinosis or cardiogenic embolism, without prior stroke, was assembled between 1976-86. Follow up was prospective and complete until the patients death or the end of 1986. During a mean period of follow up of 4-1 years there were 82 deaths (58 vascular, 24 non-vascular), 63 first-ever strokes and 58 patients with coronary events. A coronary event accounted for 51% of deaths whilst stroke was the cause in 12%. The average risk of death over the first five years after TIA was 4 5% per year. The risk of stroke was 6-6% in the first year and 3 4% per year on average over the first five years. Stroke occurred in the same vascular territory as the initial TIA in about two-thirds of cases, and was of lacunar type in one fifth of these strokes. The average risk of a coronary event over the first five years after TIA was 3-1% per year, similar to that of stroke. However, the risk of a coronary event, and also death, was fairly constant each year after a TIA, in contrast to the risk of stroke which was highest in the first year. The average risk of stroke, myocardial infarction or vascular death over the first five years after TIA was 6-5% per year and the average risk of stroke, myocardial infarction or death from any cause was 7 5% per year.
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The natural history of transient ischaemic attacks of the brain and eye (TIA), without medical intervention, is unknown. This is because most patients with TIA receive some form of treatment (for example, antihypertensive, antiplatelet, anticoagulant, carotid endarterectomy) which influences outcome, whilst other patients have never reported, nor perhaps even noticed, such transient symptoms. The prognosis of TIA, describing the outcome of TIA patients who have come under medical care and who have been treated in a variety of ways that may have affected the subsequent course of events, has been the subject of several studies with differing methods and results.'-9 The sources of variation include: a) the population (patient sample) examined: this may be community57 101119 or hospital-based,"6 12-18 with differences in referral patterns, patient selection, age structure, the presence and level of vascular diseases and risk factors, and the presence'4 '5 or absence""'52 of a history of previous stroke; b) the size of the sample: many studies are limited by small numbers""3 and consequently estimates of prognosis have wide confidence intervals; c) the definition of TIA: some studies have only included patients with TIA symptoms of one hour4 or four hours3 duration while other studies have included patients with symptoms lasting up to 72 hours and others have excluded patients with symptoms lasting less than 15 minutes;6 some studies have examined only patients with their first TIA55 1013 or an "incident" TIA,19 whereas others have studied patients who presented with a TIA, whether or not it is their first, and some studies have even included patients with merely non-focal symptoms;' d) methodology: prospective cohort study2 4 6 7 9 11 14 15 17-19 [1 - (1 -y/I00)"/5)%, where y = the percentage risk ofthe outcome event during the first five years of follow up. A 95% confidence interval (CI) was calculated for the proportion "y" by multiplying the standard error of "y" by 1-96 and adding and subtracting the product from "y".23 The 95% confidence interval for the average annual rate of each outcome event was obtained by substituting "y" in the above formula with the upper and lower 95% confidence limit of"y" successively. As many previous studies of TIA prognosis were characterised by incomplete follow up and analysis of results using non-actuarial methods, it was not possible to derive an accurate risk of survival in those studies because the patients who were lost to follow up could not be accounted for and were not censored. The studies in which the results were analysed using actuarial techniques have produced accurate survival rates (at five years,
death (and other events) was usually the arithmetic average annual risk, which was calculated by simply dividing the risk over the follow up period by the length of follow up in years. This linear approximation of the average annual risk gives a slight underestimate of the average annual risk, particularly when the risk is large. The average annual risk of various outcome events over the first five years after TIA has been recalculated, using the above formula, for the large prospective studies that provided actuarial estimates of outcome (table 4) .14 1718
The odds ratios (OR) and 95% confidence intervals for odds ratios were calculated using standard methods.23
Results

Baseline Characteristics
As in most hospital series ofpatients with TIA, these 469 patients (TCIA: n = 311, AFx: n = 158) were elderly, predominantly male, and characterised by a high prevalence of vascular disease and risk factors (table 1). The median time interval between the last TIA and evaluation by the neurologist was 10 days (interquartile range 25 days 4-29 days).
At presentation, 144 (31%) patients were being treated with drugs for hypertension, eight were taking aspirin, four were on dipyridamole and two were on oral anticogulant medication.
Cranial CT was performed on 302 patients (64%). CT was normal in 227 patients (75%) and showed evidence of widespread cortical loss (n = 33) and/or a focal area ofhypodensity (n = 52) in the other 75 patients (25%, 95% CI: 20 to 30%). The focal area of low density was in an area appropriate to the patient's symptoms in 26 patients (9%, 95% CI: 6 to 12%), 23 of whom presented with ipsilateral TCIA and three with ipsilateral AFx. In 26 patients CT showed a focal region of low density in an area unrelated to the patient's symptoms. Cerebral angiography was performed in 229 patients (49%), and seven postangiographic complications occurred in six (local 1, systemic 2, transient neurological 2, minor stroke 1, non-disabling major stroke 1). The high prevalence of disease in the symptomatic proximal ICA (fig 1) probably represents some selection bias because the asymptomatic carotid system was usually studied angiographically if a potentially operable lesion had been demonstrated by angiography on the symptomatic side. Presumed pathogenesis:
Number (%) atheroma or lipohyalinosis Number (%) cardiogenic embolism Number (%) atheroma lipohyalinosis or cardiogenic embolism Mean (SD) age in years Number (%) ofmen Number (%) of current smokers Number (%) with hypertension** Number (%) with ischaemic heart disease" Number (%) with valvular heart disease Number (%) with atrial fibrillation Number (%) with cardiac failure Number (%) with ECG evidence of LV strain or LVH Number (%) with cardiomegaly Number (%) with peripheral vascular disease" Number (%) with carotid bruit (over symptomatic artery: 108, asymptomatic artery: 75) Number (%) with arcus senilis Number (%) with residual signs Number (%) with diabetes** Mean (SD) blood glucose in mmol/l Mean (SD) plasma cholesterol in mmolfl Number (%) with hypercholesterolacmia Number (%) with haematocrit > 0 50 (median haematocrit: males 0-46, females 0-42) Number (%) with presumed infarction on CT scan (appropriate to symptoms/inappropriate to symptoms) Number (%) with history of classic or common migraine 469* 311 (66) 158 (34) (17) 148 (80) 36 (20) 69 4 (12) 103 (56) 50 (27) 91 (49) 34 (18) 39 (21) 26 (14) 21 (11) 38 (21) 72 (39) Odds ratio (95% confidence interval) pared with the community study. This significant difference in sex ratio is probably due to the lack of elderly patients (who are less commonly referred to hospital) and therefore women in our series, since the risk of having a TIA or stroke is greater in middle aged men than in women of the same age.25 2 3132 higher proportion of patients in the hospital-referred series presented with AFx, which reflects the referral patterns of the Oxford Eye Hospital.
The younger, hospital-referred patients had a greater prevalence of current cigarette smokers and the older community sample had a greater prevalence of atrial fibrillation and higher haematocrit levels. Other studies have shown that the prevalence of cigarette smokers declines in older age groups while the prevalence of atrial fibrillation increases with age.33 The time between the onset ofthe TIA and assessment by the general practitioner and subsequently the neurologist, was greater for our hospital-referred patients (10 days versus three days, medians), during which time a serious vascular event may have occurred. No great difference in treatment existed between the two populations; in the referred and community samples the respective use of aspirin was 51% and 57%, antihypertensive therapy: 38% and 44%, and carotid endarterectomy: 12% and 3%.
Diagnosis
The diagnosis of TIA is clinical and requires the skill of an experienced physician; it cannot be confirmed or rejected by any objective test or procedure and is therefore susceptible to both intraobserver and interobserver variation. Even among trained neurologists, the interobserver agreement for the diagnosis of a cerebral TIA is not very good (kappa = 065); and it is even worse for the arterial territory (kappe = 0-31)).3 38 Our sample of patients was diagnosed by a single observer, experienced in the assessment of patients with TIA, using standardised diagnostic criteria, and the diagnoses were reviewed by a second observer. It has been suggested that patients with TIA who have an appropriately sited area of low density on CT should be reclassified as cerebral infarction with transient signs (CITS) rather than a TIA.'9 0 We disagree, and have not reclassified our TIA patients, with CT evidence of appropriately-sited low density areas, as having a stroke, because: 1) the low density lesion may not be due to infarction occurring at the time of the TIA (it may be an old haemorrhage, for example); 2) the detection of ischaemic lesions on CT depends on the timing and resolution of the scan; 3) a CT scan would become essential for the diagnosis of TIA; 4) the diagnosis of TIA would then become difficult to standardise because technology varies between centres; some have no imaging, some have CT and others have MRI, which is far more sensitive, and 5) a new diagnostic category would have to be made for patients with a clinically definite stroke who have a normal CT. Also, in a recent prospective, community-based study of 120 patients with TIA, no significant differences were present in results are compared with the only large prospective community-based prognostic study of TIA'9 and three other large prospective hospital-based series in which the survival data have been analysed using actuarial methods.'41718 Although more than a quarter (28%) of the patients studied by Sorensen et al'8 had presented with a "reversible ischaemic attack" it is unlikely that this introduced significant heterogeneity from a prognostic viewpoint as the prognosis (and also prevalence of vascular disease and risk factors) in patients with minor ischaemic stroke is probably very similar to T.32 42 
Mortality
The average annual absolute mortality rates in all of the hospital-referred series were about 4-5% per year.'41718 This contrasts with the higher rate (7%) in the community,'9 which may be due to differences in the age of the patients. Between one and two thirds of all deaths were due to coronary events and about 20% of deaths were due to stroke. In the community TIA patients, the relative risk of death during follow up (mean 3-7 years) was slightly greater (1 4: 1) than the expected risk for age and sex-matched people without TIA. '9 Retrospective community-based studies in Rochester, Minnesota810 indicated that the relative risk of death was 9-6 at one month, 2-4 at one year, and about 1-5 after two years.43 The high risk at one month is quite striking but the nature of those early deaths are not known, nor the 95% confidence intervals of the estimate.
Stroke
The average annual risk of stroke during the first five years after a TIA was about 3-5% for hospital-referred patients and about 7% in the OCSP."4 [17] [18] [19] In our study, the risk of stroke was highest within the first month (about 2%) and first year (about 7%) after TIA and fell thereafter to average about 2-3% per year for the next five years. The rate of stroke in the first month depends on several factors such as the time of entry into the study and the postangiographic and post-surgical complication rates. In the retrospective studies from Rochester, Minnesota,80O43 day 0 of follow up was the date of the first-ever TIA, irrespective of whether the patient had come to medical attention or not at that time, and the stroke rate at 30 days was 8% (95% CI: 4-2 to 11-8%). In the OCSP,'9 day of follow up was taken as the day of notification to the study by the general practitioner (median three days after TIA) and the stroke rate at 30 days was 4 4% (95% CI: 1 5 to 7 3%). In our study, day 0 was the day of neurological consultation (median 10 days after TIA), and the 30 day stroke rate was 2-1% (95% CI: 0-8 to 3-5%). These results illustrate the approximate risk of stroke for TIA patients from the point of view of awareness to the patient, to the general practitioner and to the neurologist, respectively. In the study by angiographic and endarterectomy strokes were excluded). The lack of any excess early risk of a coronary event (compared with stroke) probably reflects the lack of iatrogenic coronary events. Also, we assume that in some patients at least, an "active' atherosclerotic plaque in the cerebral circulation has caused the TIA and is likely to cause a stroke soon after. The occurrence of TIA is as much a predictor of a cardiovascular event as it is of a cerebrovascular event and therapeutic endeavours need to be directed with equal energy and resources into the prevention of ischaemic cardiac events as ischaemic cerebral and ocular events.
Other serious vascular events The risk of having a disabling major stroke or vascular death, which is probably what concerns the patient principally, was about 4% per year over the first five years in our study. The probability of having a serious vascular event, such as a stroke, myocardial infarction or vascular death, which is what is potentially amenable to antithrombotic treatment24" (as well as control of vascular risk factors), was about 6-5% per year in this hospital-referred series and 8-6% per year in the community study.
Impact of referral bias on prognosis
The better prognosis of the hospital-referred population probably reflects: 1) their younger age, 2) the greater proportion of AFx (which has a better prognosis than TCIA,'9 and 3) the longer delay until assessment and entry into the study.
Impact ofprognostic factors on prognosis Most studies, including our own, have considered TIA patients more or less as a single group (although we only studied TIA due to presumed atheromatous arterial disease, lipohyalinosis or cardiac disease). Such analysis ignores the considerable range of prognoses that must be present in any TIA population. The presence of one risk factor, such as age, does not necessarily imply a bad prognosis, only an increased risk. However, as the number of risk factors/poor prognostic factors increases, the prognosis of the patient declines. Differences in the prevalence and level of these adverse prognostic factors and in treatment among different populations of TIA patients may offer some explanation for the variation in reported results of prognosis. It is very difficult to identify which particular factors are responsible for the relatively favourable prognosis of TIA patients in our cohort compared with other hospital-referred studies. Although the mean age of patients was similar among the different studies, information about other prognostic factors and treatments, common to all studies, is generally lacking. Later, we shall be reporting the significant prognostic factors in this cohort.
Our results come from one population of TIA patients who were referred to a neurologist with an interest in cerebrovascular disease and have been compared with one communitybased study in the same geographical area and other prospective hospital-referred series. Although care is needed in extrapolating the results to other populations of TIA patients, this sample of patients is probably quite similar, in terms of age, prevalence of vascular diseases and risk factors and prognosis, to other hospital-referred populations and can be used in planning diagnostic strategies, treatment, and treatment trials in such populations.
